Business Context and Reporting Period
This Form 8-K, dated December 12, 2025, is a current report filed by CompoSecure, Inc. (NYSE: CMPO). The filing serves as a voluntary supplemental disclosure to a previously filed Proxy Statement regarding a proposed transaction to acquire Husky Technologies Limited ("Husky"). The supplement was issued in response to shareholder demand letters and three separate lawsuits alleging material omissions in the original Proxy Statement. A special shareholder meeting to vote on the transaction is scheduled for December 23, 2025.
Key Financial Metrics and Transaction Terms
The filing details the financial structure of the proposed acquisition and related financing:
- Transaction Consideration: Approximately $4.976 billion in aggregate value, consisting of $3.953 billion in cash and 55,297,297 shares of CompoSecure Class A Common Stock.
- Financing: A private placement of 106,056,083 shares of Common Stock at $18.50 per share, raising approximately $1.96 billion.
- Valuation Multiples (Comparable Companies):
- Industrial After Market Peers (2025E AV/EBITDA): Range from 14.7x to 16.9x.
- Food and Beverage Machinery Peers (2025E AV/EBITDA): Range from 6.0x to 14.4x.
- Discounted Cash Flow (DCF) Analysis for Husky: Implied enterprise value range of $4.917 billion to $6.961 billion based on projected terminal year unlevered free cash flow of $460 million.
- Pro Forma Net Debt: Estimated at approximately $1,692 million (2026), $1,273 million (2027), and $713 million (2028).
- CompoSecure Net Cash: Estimated at $75 million as of the analysis date.
Material Changes and Litigation
The primary material change disclosed is the amendment of financial analysis sections in the Proxy Statement to provide specific valuation data previously omitted. Additionally, the filing discloses active legal challenges:
- Shareholder Litigation: Three complaints have been filed (two in New York Supreme Court, one in New Jersey Superior Court) alleging negligence, misrepresentation, and concealment regarding the Proxy Statement.
- Shareholder Demands: Multiple demand letters have been sent alleging disclosure deficiencies, and a Section 220 demand has been filed to inspect company books and records.
- Company Stance: CompoSecure asserts the claims are without merit and denies any legal necessity for the supplemental disclosure, issuing it solely to mitigate litigation risk and delay.
- Husky Projections: Terminal year unlevered free cash flow of $460 million with perpetual growth rates of 2.5% to 3.5%.
- CompoSecure Projections: Terminal year unlevered free cash flow of $209 million with perpetual growth rates of 2.5% to 3.5%.
- Discount Rates: Ranges of 9.3% to 11.0% for Husky and 9.5% to 11.3% for CompoSecure.
- Transaction Completion: Risks include failure to obtain regulatory or shareholder approval, termination of the Share Purchase Agreement, and financing failures.
- Legal Uncertainty: Potential for injunctions barring the transaction or damages if the transaction is consummated.
- Advisor Conflicts: Morgan Stanley is a lender to Platinum Equity (a seller affiliate) and has received $10 million to $20 million in fees from Platinum in the prior two years, which may exceed fees from CompoSecure.
- Verify the status of the three pending shareholder lawsuits and any court rulings regarding injunctions before the December 23, 2025, special meeting.
- Review the full Proxy Statement to compare the newly disclosed valuation multiples and DCF assumptions against the original filing.
- Assess the potential impact of Morgan Stanley's financial relationships with Platinum Equity on the fairness opinion provided.
- Confirm the final terms of the private placement financing and the actual cash proceeds received.
- Monitor the pro forma net debt levels ($1.692 billion in 2026) against the company's ability to service this debt post-transaction.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing includes updated financial projections used by financial advisor Morgan Stanley. These include: